217 related articles for article (PubMed ID: 37107181)
1. Oxidative Stress and Antioxidants in Uterine Fibroids: Pathophysiology and Clinical Implications.
AlAshqar A; Lulseged B; Mason-Otey A; Liang J; Begum UAM; Afrin S; Borahay MA
Antioxidants (Basel); 2023 Mar; 12(4):. PubMed ID: 37107181
[TBL] [Abstract][Full Text] [Related]
2. Predictors of response for elagolix with add-back therapy in women with heavy menstrual bleeding associated with uterine fibroids.
Al-Hendy A; Bradley L; Owens CD; Wang H; Barnhart KT; Feinberg E; Schlaff WD; Puscheck EE; Wang A; Gillispie V; Hurtado S; Muneyyirci-Delale O; Archer DF; Carr BR; Simon JA; Stewart EA
Am J Obstet Gynecol; 2021 Jan; 224(1):72.e1-72.e50. PubMed ID: 32702363
[TBL] [Abstract][Full Text] [Related]
3. MicroRNAs in the development and pathobiology of uterine leiomyomata: does evidence support future strategies for clinical intervention?
Karmon AE; Cardozo ER; Rueda BR; Styer AK
Hum Reprod Update; 2014; 20(5):670-87. PubMed ID: 24706045
[TBL] [Abstract][Full Text] [Related]
4. The role of angiogenic factors in fibroid pathogenesis: potential implications for future therapy.
Tal R; Segars JH
Hum Reprod Update; 2014; 20(2):194-216. PubMed ID: 24077979
[TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of the selective progesterone receptor modulator asoprisnil for heavy menstrual bleeding with uterine fibroids: pooled analysis of two 12-month, placebo-controlled, randomized trials.
Stewart EA; Diamond MP; Williams ARW; Carr BR; Myers ER; Feldman RA; Elger W; Mattia-Goldberg C; Schwefel BM; Chwalisz K
Hum Reprod; 2019 Apr; 34(4):623-634. PubMed ID: 30865281
[TBL] [Abstract][Full Text] [Related]
6. Evidence of biomechanical and collagen heterogeneity in uterine fibroids.
Jayes FL; Liu B; Feng L; Aviles-Espinoza N; Leikin S; Leppert PC
PLoS One; 2019; 14(4):e0215646. PubMed ID: 31034494
[TBL] [Abstract][Full Text] [Related]
7. Uterine fibroids and cardiovascular risk.
Uimari O; Auvinen J; Jokelainen J; Puukka K; Ruokonen A; Järvelin MR; Piltonen T; Keinänen-Kiukaanniemi S; Zondervan K; Järvelä I; Ryynänen M; Martikainen H
Hum Reprod; 2016 Dec; 31(12):2689-2703. PubMed ID: 27733532
[TBL] [Abstract][Full Text] [Related]
8. Oxidative stress markers in uterine fibroids tissue in pre- and postmenopausal women.
Markowska A; Mardas M; Gajdzik E; Zagrodzki P; Markowska J
Clin Exp Obstet Gynecol; 2015; 42(6):725-9. PubMed ID: 26753472
[TBL] [Abstract][Full Text] [Related]
9. Proceedings from the Third National Institutes of Health International Congress on Advances in Uterine Leiomyoma Research: comprehensive review, conference summary and future recommendations.
Segars JH; Parrott EC; Nagel JD; Guo XC; Gao X; Birnbaum LS; Pinn VW; Dixon D
Hum Reprod Update; 2014; 20(3):309-33. PubMed ID: 24401287
[TBL] [Abstract][Full Text] [Related]
10. Uterine fibroid vascularization: from morphological evidence to clinical implications.
Ciarmela P; Delli Carpini G; Greco S; Zannotti A; Montik N; Giannella L; Giuliani L; Grelloni C; Panfoli F; Paolucci M; Pierucci G; Ragno F; Pellegrino P; Petraglia F; Ciavattini A
Reprod Biomed Online; 2022 Feb; 44(2):281-294. PubMed ID: 34848152
[TBL] [Abstract][Full Text] [Related]
11. Epidemiological and genetic clues for molecular mechanisms involved in uterine leiomyoma development and growth.
Commandeur AE; Styer AK; Teixeira JM
Hum Reprod Update; 2015; 21(5):593-615. PubMed ID: 26141720
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of 25-hydroxy vitamin D3 levels in patients with a fibroid uterus.
Srivastava P; Gupta HP; Singhi S; Khanduri S; Rathore B
J Obstet Gynaecol; 2020 Jul; 40(5):710-714. PubMed ID: 31635506
[TBL] [Abstract][Full Text] [Related]
13. The management of uterine fibroids in women with otherwise unexplained infertility.
Carranza-Mamane B; Havelock J; Hemmings R; ;
J Obstet Gynaecol Can; 2015 Mar; 37(3):277-285. PubMed ID: 26001875
[TBL] [Abstract][Full Text] [Related]
14. Selective progesterone receptor modulators (SPRMs) for uterine fibroids.
Murji A; Whitaker L; Chow TL; Sobel ML
Cochrane Database Syst Rev; 2017 Apr; 4(4):CD010770. PubMed ID: 28444736
[TBL] [Abstract][Full Text] [Related]
15. Preoperative medical therapy before surgery for uterine fibroids.
Lethaby A; Puscasiu L; Vollenhoven B
Cochrane Database Syst Rev; 2017 Nov; 11(11):CD000547. PubMed ID: 29139105
[TBL] [Abstract][Full Text] [Related]
16. Aberrant expression and regulation of NR2F2 and CTNNB1 in uterine fibroids.
Zaitseva M; Holdsworth-Carson SJ; Waldrip L; Nevzorova J; Martelotto L; Vollenhoven BJ; Rogers PA
Reproduction; 2013 Aug; 146(2):91-102. PubMed ID: 23704310
[TBL] [Abstract][Full Text] [Related]
17. Factors influencing the dosimetry for high-intensity focused ultrasound ablation of uterine fibroids: a retrospective study.
Peng S; Zhang L; Hu L; Chen J; Ju J; Wang X; Zhang R; Wang Z; Chen W
Medicine (Baltimore); 2015 Apr; 94(13):e650. PubMed ID: 25837756
[TBL] [Abstract][Full Text] [Related]
18. Two novel classification systems for uterine fibroids and subsequent uterine reconstruction after myomectomy.
Juhasz-Böss I; Jungmann P; Radosa J; von Heesen A; Ströder R; Juhasz-Böss S; Meyberg-Solomayer G; Solomayer E
Arch Gynecol Obstet; 2017 Mar; 295(3):675-680. PubMed ID: 28000025
[TBL] [Abstract][Full Text] [Related]
19. Uterine fibroids are characterized by an impaired antioxidant cellular system: potential role of hypoxia in the pathophysiology of uterine fibroids.
Fletcher NM; Saed MG; Abu-Soud HM; Al-Hendy A; Diamond MP; Saed GM
J Assist Reprod Genet; 2013 Jul; 30(7):969-74. PubMed ID: 23812845
[TBL] [Abstract][Full Text] [Related]
20. Uterine fibroid size modifications during pregnancy and puerperium: evidence from the first systematic review of literature.
Vitagliano A; Noventa M; Di Spiezio Sardo A; Saccone G; Gizzo S; Borgato S; Vitale SG; Laganà AS; Nardelli GB; Litta PS; Saccardi C
Arch Gynecol Obstet; 2018 Apr; 297(4):823-835. PubMed ID: 29236171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
